Unilever shares fall 6%, GSK gainsUnilever signals it would pursue offer for GSK unitSays dedicated to “strict monetary discipline”Jan 17 (Reuters) – Unilever (ULVR.L) signalled on Monday it would pursue a deal for GlaxoSmithKlines (GSK.L) customer health service, calling it a “strong tactical fit” after its 50-billion-pound ($68.4 billion) deal was turned down, sending its shares down 6%. GSK validated over the weekend that it had actually declined the Dove soap makers bid for its customer healthcare company, which is home to brands such as Sensodyne toothpaste and Emergen-C vitamin supplement. Unilever did not immediately react to a Reuters demand for comment on the talks.
